MY ACCOUNT | NEWSLETTER |

Animal health company, AnimalBiome, has closed a series A with $8.6 million in funding


Animal health company, AnimalBiome, has closed a series A with $8.6 million in funding led by Cargill, and including biologic and venture capital firms, and Michelson Found Animal Foundation. The injection of funding will be used toward growth and to develop companion animal-focused microbial cocktails, according to the company.

AnimalBiome targets the gut microbiome to aid pets with digestive and skin disorders, an industry which accounts for about $14 billion in treatments, according to the company. "As leaders in companion animal microbiome research, we're seeking to get to the root of the digestive and skin problems affecting our pets," said Carlton Osborne, AnimalBiome co-founder and CEO. "Working together with Cargill, we have the unique advantage of science and industry leadership to tackle some of the pet health industry's most challenging and heart-breaking issues.”

The company was founded in 2016 by UC Berkeley and UC Davis researchers, and has focused on improving and maintaining digestive health in cats and dogs. AnimalBiome has launched a DTC microbiome testing platform for pets which provides information to both the pet’s veterinarian and pet owner. The test results are also accompanied by a report that outlines dietary and supplement changes the pet owner can make to improve the pet’s microbiome. The company also offers a proprietary suite of supplements.

"Our research shows that pets with chronic gut and skin conditions are often missing key beneficial gut bacteria, which is correlated with exposure to antimicrobials commonly used in veterinary practice, and that in many cases restoring them alleviates signs of disease," said Holly Ganz, AnimalBiome co-founder and Chief Science Officer. "This investment allows us to accelerate our discovery of key beneficial gut microbes and design the next generation of pet probiotics."

Source: https://www.prnewswire.com/news-releases/animalbiome-closes-8-6-million-series-a-investment-round-positioning-the-pet-microbiome-innovator-to-create-novel-microbial-cocktails-for-companion-animals-301347830.html


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Corneal calcareous degeneration and various ophthalmic diseases in dogs

Like0
Dislike0

Management of uroperitoneum through combination of conservative and surgical treatments in colts

Like0
Dislike0

Genetic Focus on Improving Animal Protein Sustainability

Like0
Dislike0

Multi-agency report highlights importance of reducing antibiotic use

Like0
Dislike0

Antiviral combination treatment in cats with feline herpesvirus-1 infection

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top